RUO優妥尤單抗是一種全人源IgG 2激動劑mAb,可選擇性結合人4- 1 BB/CD 137,導致細胞系和原代淋巴細胞中NF-κB活化和下游細胞因子產生。優妥尤單抗可誘導人白細胞增殖,并在人外周血淋巴細胞(PBL)SCID異種移植腫瘤模型中作為單藥顯示出顯著的抗腫瘤活性。 優妥尤單抗生物仿制藥-研究級該產品同種型對照:Bulk Human IgG2 Isotype Control (IB2) [ICH2255] 緩沖液:ICH3002 濃度:5mg/ml 純度:>95% by SDS-PAGE 內毒素:≤ 1.0 EU/mg as determined by the LAL method 制劑:Sterile, preservative-free, solution in PBS. BSA and Azide free.